Arch Biopartners Inc. Arranges Non-Brokered Private Placement
Arch Biopartners Inc. has announced a non-brokered private placement to raise $900,000 CAD to support its clinical trial programs and general operations.
Stocks · News reference
What Is Going On With Joby Aviation Stock Today?
Joby Aviation stock rises modestly as traders weigh Blade news, the Archer legal dispute and a firmer broader market.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Canaccord Genuity Upgrades Joby Aviation to Buy
Canaccord Genuity upgraded Joby Aviation's stock rating to Buy from Hold while lowering its price target to $7 from $11.50.
CCORF Upgrades Joby Aviation to Buy Rating
Analyst Austin Moeller of CCORF upgraded Joby Aviation to a buy rating while adjusting the price target to $7 from $11.50.
Joby Aviation Reports Q3 2026 Financial Results
Joby Aviation reported Q3 2026 revenue of $55.1 million, a 144% year-over-year increase driven by the acquisition of Blade Air Mobility's passenger business.
Needham Lowers Price Target for Joby Aviation
Needham has adjusted its price target for Joby Aviation, reducing it from $15 to $10.
Could Archer Aviation Stock Make You a Millionaire by 2036?
Archer Aviation, an eVTOL aircraft manufacturer, could benefit from a massive urban air mobility market projected to reach $1 trillion by 2040. However, the company faces significant challenges in commercializing its air taxi business by 2036 and is currently trading 60% lower than last year. While the long-term opportunity is substantial, investors should understand the speculative nature and execution risks before investing.